Fulton Breakefield Broenniman LLC Merck & Co., Inc. Transaction History

Fulton Breakefield Broenniman LLC

  • $1.41 Billion
  • Q3 2024

A detailed history of Fulton Breakefield Broenniman LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fulton Breakefield Broenniman LLC holds 8,428 shares of MRK stock, worth $828,809. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,428
Previous 8,947 5.8%
Holding current value
$828,809
Previous $1.11 Million 13.55%
% of portfolio
0.07%
Previous 0.08%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
SELL
$111.15 - $128.97 $57,686 - $66,935
-519 Reduced 5.8%
8,428 $957,000
Q2 2024

Aug 07, 2024
BUY
$123.8 - $132.96 $78,613 - $84,429
635 Added 7.64%
8,947 $1.11 Million
Q1 2024

Apr 29, 2024
SELL
$113.24 - $131.95 $12,116 - $14,118
-107 Reduced 1.27%
8,312 $1.1 Million
Q4 2023

Feb 02, 2024
SELL
$100.18 - $109.02 $112,902 - $122,865
-1,127 Reduced 11.81%
8,419 $917,000
Q3 2023

Oct 20, 2023
SELL
$102.95 - $114.33 $10,192 - $11,318
-99 Reduced 1.03%
9,546 $982,000
Q2 2023

Jul 19, 2023
SELL
$108.61 - $118.38 $165,956 - $180,884
-1,528 Reduced 13.68%
9,645 $1.11 Million
Q1 2023

Apr 25, 2023
SELL
$102.94 - $114.86 $49,514 - $55,247
-481 Reduced 4.13%
11,173 $1.19 Million
Q4 2022

Jan 31, 2023
BUY
$87.44 - $112.11 $3,585 - $4,596
41 Added 0.35%
11,654 $1.29 Million
Q3 2022

Oct 17, 2022
BUY
$84.53 - $94.96 $676 - $759
8 Added 0.07%
11,613 $1 Million
Q2 2022

Jul 28, 2022
SELL
$83.49 - $94.64 $7,764 - $8,801
-93 Reduced 0.8%
11,605 $1.06 Million
Q1 2022

Apr 27, 2022
BUY
$73.51 - $82.4 $115,337 - $129,285
1,569 Added 15.49%
11,698 $960,000
Q4 2021

Feb 07, 2022
BUY
$72.28 - $90.54 $4,119 - $5,160
57 Added 0.57%
10,129 $776,000
Q3 2021

Oct 25, 2021
SELL
$71.68 - $78.83 $43,008 - $47,298
-600 Reduced 5.62%
10,072 $757,000
Q2 2021

Jul 27, 2021
SELL
$70.31 - $77.77 $1,757 - $1,944
-25 Reduced 0.23%
10,672 $830,000
Q1 2021

Apr 09, 2021
BUY
$68.86 - $81.11 $324,674 - $382,433
4,715 Added 78.82%
10,697 $825,000
Q4 2020

Jan 14, 2021
SELL
$71.77 - $79.65 $398,682 - $442,455
-5,555 Reduced 48.15%
5,982 $489,000
Q3 2020

Oct 20, 2020
SELL
$73.18 - $82.95 $3,732 - $4,230
-51 Reduced 0.44%
11,537 $957,000
Q2 2020

Jul 10, 2020
BUY
$70.42 - $80.13 $5,281 - $6,009
75 Added 0.65%
11,588 $896,000
Q1 2020

Apr 10, 2020
SELL
$63.36 - $87.82 $75,271 - $104,330
-1,188 Reduced 9.35%
11,513 $886,000
Q4 2019

Jan 14, 2020
BUY
$77.58 - $87.54 $121,412 - $137,000
1,565 Added 14.05%
12,701 $1.16 Million
Q3 2019

Oct 17, 2019
BUY
$76.08 - $82.93 $847,226 - $923,508
11,136 New
11,136 $937,000

Others Institutions Holding MRK

# of Institutions
3,828
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fulton Breakefield Broenniman LLC Portfolio

Follow Fulton Breakefield Broenniman LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email